Page last updated: 2024-08-23

pravastatin and mocetinostat

pravastatin has been researched along with mocetinostat in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouchier-Hayes, DJ; Chen, G; Joyce, M; Kelly, CJ1
Bulhak, AA; Gonon, AT; Gourine, AV; Pernow, J; Sjöquist, PO; Valen, G1
Mao, LG; Yao, HW; Zhu, JP1
Chen, J; Hashimoto, K; Mitsui, K; Nagasawa, Y; Shen, H; Tsurugi, K1
Harada, M; Otani, M; Otsuki, M; Yamamoto, M1

Trials

1 trial(s) available for pravastatin and mocetinostat

ArticleYear
Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2001, Volume: 21, Issue:4

    Topics: Analysis of Variance; Animals; Blotting, Western; Bronchoalveolar Lavage Fluid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung; Male; Neutrophils; Nitric Oxide Synthase; Peroxidase; Pravastatin; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Up-Regulation

2001

Other Studies

4 other study(ies) available for pravastatin and mocetinostat

ArticleYear
Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
    Acta physiologica Scandinavica, 2005, Volume: 183, Issue:2

    Topics: Administration, Oral; Animals; Blood Pressure; Cholesterol; Female; Fluorobenzenes; Heart; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophil Infiltration; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peroxidase; Pravastatin; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Swine

2005
Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury.
    Clinical and experimental pharmacology & physiology, 2006, Volume: 33, Issue:9

    Topics: Albumins; Animals; Anticholesteremic Agents; Bronchoalveolar Lavage Fluid; Cell Count; Cytoprotection; Drug Evaluation, Preclinical; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Organ Size; Peroxidase; Pravastatin; Respiratory Distress Syndrome; Respiratory Function Tests; Tumor Necrosis Factor-alpha

2006
Pravastatin inhibits arrhythmias induced by coronary artery ischemia in anesthetized rats.
    Journal of pharmacological sciences, 2007, Volume: 103, Issue:3

    Topics: Administration, Oral; Anesthesia; Animals; Arrhythmias, Cardiac; Coronary Vessels; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl CoA Reductases; Indoles; Ischemia; Male; Peroxidase; Pravastatin; Rats; Rats, Sprague-Dawley

2007
Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka-Long-Evans-Tokushima fatty rat.
    British journal of pharmacology, 2010, Jan-01, Volume: 159, Issue:2

    Topics: Adipose Tissue, White; Animals; Apoptosis; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Fibrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Organ Size; Pancreas; Peroxidase; Pravastatin; Rats; Rats, Long-Evans; Superoxide Dismutase; Time Factors; Transforming Growth Factor beta1; Triglycerides; Tumor Necrosis Factor-alpha

2010